University of Florida

Environmental Health & Safety

Skip to main Content   Local Links   Search   Main Navigation   Quick Links   Resources   Website   Social   Address   What is this view

Main Navigation

Quick Links

Home   Programs   Biological Safety   Biosafety Guidelines for CRISPR-cas Research CRISPR Biosafety Guidance

CRISPR Biosafety Guidance

If non-human sgRNA, what is the % homology to human guide sequences? More homology = more risk.
Experimental risk is higher if using amphotropic or pantropic retrovirus, lentivirus, especially to express human viral/cellular oncogenes or knock-down human suppressor genes. Watch for generation of replication competent retro/lentiviruses, insertional mutagenesis, expression of oncogenes and exposure of lung epithelium to aerosolized viral particles, and needlestick accidents.
The altered gene is always inherited in offspring; without containment the offspring rapidly out-compete natural population. If so, please refer to items below.
  • Delivering a DNA cassette encoding the Cas9 gene and a single sgRNA flanked with sequences homologous to the target sequences can create a gene drive by continued expression and copying of the cassette converting heterozygotes to homozygotes
  • Separate constructs provide molecular control; deletion/mutation/insertion does not occur until both constructs combined
  • Use of standard plasmid constructs recommended over replication competent virus (see above)
  • What are the possible effects on the host population due to changes in the organism?
  • What happens if the organism/ materials/altered animal are released in the environment?

Use at least 2 of the following strategies to ensure required control measures are met:

  • Molecular: split drive or 2-step editing: sgRNA and Cas9 placed on separate loci e.g. generate stable Cas9 cell line and deliver sgRNA into it (deletion/mutation/insertion occurs only in the transgenic Cas9-expressing organisms) or target synthetic sequences (deletion/mutation/insertion occurs only in organisms engineered with the target sequence). Also, use of reversal drives to overwrite the original.
  • Ecological: Use the gene drive system where escaped organisms cannot find mates or persist in the outside environment.
  • Reproductive: Use laboratory hosts/organisms that cannot reproduce with wild hosts/organisms
  • Barrier/Containment: Prevent organisms from escaping from the lab, e.g. triply-nested containers, >3 doors, etc.

Consider and evaluate the following questions:

  • How will you determine the unknown off-target effects/mutations?
  • How much genotype change is needed to cause an apparent physical effect?
  • What are the human/animal exposure concerns with the CRISPR-cas system, vector, cells or organisms used or due to the off-target effects?
Consider and evaluate if there are antibiotic resistance, increased lethality, or disease transmission being introduced or if these can occur accidentally.

Using proper lab procedures and following Biosafety office and/or IBC requirements:

  • Modify research design to lower risk, if feasible
  • Apply specific organismal, containment and/or procedural controls

Footer

Resources

Website

Utility Links

New PI? Get EH&S Help

Social links

Address

What is this view?

You are using a dynamic assistive view of the University of Florida site. It has all the same data and features of the original site but formatted just with assistive users in mind. It has links and content reorganized to aid assistive users and has controls at the bottom under assistive options that allow you to control key aspects such as font size and contrast colors etc.
This is not a separate text-only site, it's a dynamic view that uses unique technology from Usablenet to give assistive users better, more accessible access to the same content and features as all users that use the graphic view of the site.

Assistive Options

Top of page


Assistive Options

Open the original version of this page.

Usablenet Assistive is a Usablenet product. Usablenet Assistive Main Page.